SevenFact
Biological
HEMA Biologics, LLC
Total Payments
$1.9M
Transactions
2,046
Doctors
210
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $475,757 | 451 | 89 |
| 2023 | $724,484 | 808 | 78 |
| 2022 | $459,364 | 479 | 65 |
| 2021 | $264,030 | 308 | 50 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $969,142 | 278 | 50.4% |
| Unspecified | $364,775 | 59 | 19.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $316,908 | 124 | 16.5% |
| Travel and Lodging | $191,013 | 567 | 9.9% |
| Food and Beverage | $51,296 | 867 | 2.7% |
| Honoraria | $26,870 | 9 | 1.4% |
| Grant | $2,500 | 1 | 0.1% |
| Space rental or facility fees (teaching hospital only) | $500.00 | 1 | 0.0% |
| Gift | $370.55 | 124 | 0.0% |
| Education | $260.52 | 16 | 0.0% |
Payments by Type
General
$1.6M
1,987 transactions
Research
$364,775
59 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| ATHN 16 | HEMA Biologics, LLC | $218,000 | 0 |
| A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM | HEMA Biologics, LLC | $87,300 | 3 |
| Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT | HEMA Biologics, LLC | $59,475 | 0 |
Top Doctors Receiving Payments for SevenFact — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Pediatric Hematology-Oncology | Ann Arbor, MI | $3,350 | 1 |
| , PA | Physician Assistant | Winston Salem, NC | $3,254 | 11 |
| , MD | Hematology | Charlotte, NC | $3,100 | 1 |
| , DO | Pediatric Hematology-Oncology | Las Vegas, NV | $3,025 | 1 |
| , MD | Pediatric Hematology-Oncology | Indianapolis, IN | $3,012 | 5 |
| , M.D | Hematology & Oncology | Arlington, VA | $3,000 | 1 |
| , D.O | Pediatric Hematology-Oncology | Temple, TX | $2,871 | 7 |
| , C.N.P | Nurse Practitioner | Detroit, MI | $2,792 | 10 |
| , MD | Pediatric Hematology-Oncology | Memphis, TN | $2,750 | 1 |
| , MD, PHD | Pediatrics | Toledo, OH | $2,624 | 7 |
| , MD | Specialist | Williamsville, NY | $2,611 | 10 |
| , MD | Hematology & Oncology | Louisville, KY | $2,551 | 4 |
| , MD | Hematology & Oncology | Milwaukee, WI | $2,545 | 7 |
| , M.D | Pediatrics | Nashville, TN | $2,539 | 8 |
| , MD | Pediatrics | Ann Arbor, MI | $2,520 | 7 |
| , M.D | Internal Medicine | Detroit, MI | $2,520 | 7 |
| , MD | Pediatric Hematology-Oncology | Cincinnati, OH | $2,520 | 7 |
| , MD | Pediatric Hematology-Oncology | Aurora, CO | $2,520 | 7 |
| , MD | Hematology & Oncology | Dallas, TX | $2,520 | 7 |
| , M.D | Hematology & Oncology | San Antonio, TX | $2,520 | 7 |
| , M.D | Internal Medicine | Atlanta, GA | $2,515 | 6 |
| , MD | Pediatrics | Chicago, IL | $2,515 | 6 |
| , MD | Pediatric Hematology-Oncology | Columbus, OH | $2,515 | 6 |
| , MD | Pediatrics | Washington, DC | $2,515 | 6 |
| , M.D | Pediatric Hematology-Oncology | New York, NY | $2,515 | 6 |
Ad
Manufacturing Companies
- HEMA Biologics, LLC $1.9M
Product Information
- Type Biological
- Total Payments $1.9M
- Total Doctors 210
- Transactions 2,046
About SevenFact
SevenFact is a biological associated with $1.9M in payments to 210 healthcare providers, recorded across 2,046 transactions in the CMS Open Payments database. The primary manufacturer is HEMA Biologics, LLC.
Payment data is available from 2021 to 2024. In 2024, $475,757 was paid across 451 transactions to 89 doctors.
The most common payment nature for SevenFact is "Consulting Fee" ($969,142, 50.4% of total).
SevenFact is associated with 3 research studies, including "ATHN 16" ($218,000).